BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 32101058)

  • 1. Updates in Histologic Grading of Urologic Neoplasms.
    Rice-Stitt T; Valencia-Guerrero A; Cornejo KM; Wu CL
    Arch Pathol Lab Med; 2020 Mar; 144(3):335-343. PubMed ID: 32101058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contemporary Grading and Staging of Urothelial Neoplasms of the Urinary Bladder: New Concepts and Approaches to Challenging Scenarios.
    Gallan AJ; Choy B; Paner GP
    Surg Pathol Clin; 2018 Dec; 11(4):775-795. PubMed ID: 30447841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reproducibility and reliability of tumor grading in urological neoplasms.
    Engers R
    World J Urol; 2007 Dec; 25(6):595-605. PubMed ID: 17828603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray.
    Higgins JP; Kaygusuz G; Wang L; Montgomery K; Mason V; Zhu SX; Marinelli RJ; Presti JC; van de Rijn M; Brooks JD
    Am J Surg Pathol; 2007 May; 31(5):673-80. PubMed ID: 17460449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tumor markers in the histopathology of urologic tumors].
    Hofstädter F
    Urologe A; 1987 Jan; 26(1):2-6. PubMed ID: 3576859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Precursor Lesions of Urologic Malignancies.
    Khani F; Robinson BD
    Arch Pathol Lab Med; 2017 Dec; 141(12):1615-1632. PubMed ID: 28767283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histologic grading of urothelial carcinoma: a reappraisal.
    Cheng L; MacLennan GT; Lopez-Beltran A
    Hum Pathol; 2012 Dec; 43(12):2097-108. PubMed ID: 22542126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triple malignancy of the genitourinary tract.
    Dieckmann KP; Nekarda H
    Int Urol Nephrol; 1988; 20(5):485-8. PubMed ID: 3235299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Updates in the Eighth Edition of the Tumor-Node-Metastasis Staging Classification for Urologic Cancers.
    Paner GP; Stadler WM; Hansel DE; Montironi R; Lin DW; Amin MB
    Eur Urol; 2018 Apr; 73(4):560-569. PubMed ID: 29325693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Grading of Urothelial Carcinoma and The New "World Health Organisation Classification of Tumours of the Urinary System and Male Genital Organs 2016".
    Compérat EM; Burger M; Gontero P; Mostafid AH; Palou J; Rouprêt M; van Rhijn BWG; Shariat SF; Sylvester RJ; Zigeuner R; Babjuk M
    Eur Urol Focus; 2019 May; 5(3):457-466. PubMed ID: 29366854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The current status of renal cell carcinoma and prostate carcinoma grading.
    Delahunt B; Egevad L; Yaxley J; Samaratunga H
    Int Braz J Urol; 2018; 44(6):1057-1062. PubMed ID: 30516924
    [No Abstract]   [Full Text] [Related]  

  • 12. Clear cell neoplasms of the urinary tract and male reproductive system.
    Humphrey PA
    Semin Diagn Pathol; 1997 Nov; 14(4):240-52. PubMed ID: 9383824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gleason and Fuhrman no longer make the grade.
    Delahunt B; Egevad L; Samaratunga H; Martignoni G; Nacey JN; Srigley JR
    Histopathology; 2016 Mar; 68(4):475-81. PubMed ID: 26266664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging critical role of molecular testing in diagnostic genitourinary pathology.
    Netto GJ; Cheng L
    Arch Pathol Lab Med; 2012 Apr; 136(4):372-90. PubMed ID: 22458900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Grading and prognostic significance of urologic carcinomas.
    Helpap B
    Urol Int; 1992; 48(3):245-57. PubMed ID: 1589911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selected common diagnostic problems in urologic pathology: perspectives from a large consult service in genitourinary pathology.
    Brimo F; Epstein JI
    Arch Pathol Lab Med; 2012 Apr; 136(4):360-71. PubMed ID: 22458899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triple synchronous genitourinary malignancies of dissimilar histogenesis.
    Wentworth SA; Head RW; Stewart R
    Urology; 1985 Mar; 25(3):313. PubMed ID: 3976123
    [No Abstract]   [Full Text] [Related]  

  • 18. Does solitary- and organ-confined metastasectomy really improve survival in advanced urologic malignancies?
    Tonyali S; Yazici S
    Int Urol Nephrol; 2016 May; 48(5):671-80. PubMed ID: 26843415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Updates in Staging and Reporting of Genitourinary Malignancies.
    Cornejo KM; Rice-Stitt T; Wu CL
    Arch Pathol Lab Med; 2020 Mar; 144(3):305-319. PubMed ID: 32101056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part B: Prostate and Bladder Tumours.
    Humphrey PA; Moch H; Cubilla AL; Ulbright TM; Reuter VE
    Eur Urol; 2016 Jul; 70(1):106-119. PubMed ID: 26996659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.